menu search

zevra therapeutics to report third quarter 2023 results on november 7, 2023, at 8:00 a.m. et

CELEBRATION, Fla., Oct. 31, 2023 (GLOBE NEWSWIRE) -- zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (...

October 31, 2023, 7:30 am

zevra therapeutics celebrates and supports global niemann-pick disease awareness day on october 19th and niemann-pick disease awareness month throughout october

CELEBRATION, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) — zevra Therapeutics, Inc. (NasdaqGS: ZVRA), a rare...

October 19, 2023, 11:30 am

zevra therapeutics appoints neil f. mcfarlane as president, chief executive officer and director

Christal Mickle transitions back to Chief Development Officer CELEBRATION, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) — ...

October 10, 2023, 11:30 am

zevra therapeutics to present at the 52nd child neurology society annual meeting

Presentation to focus on the arimoclomol program for the treatment of Niemann-Pick Disease type C and related early access programs...

October 5, 2023, 7:30 am

zevra's rare find: unearthing value in niche rare diseases the market overlooks

zevra's acquisition of Acer Therapeutics adds significant value to its rare disease-focused strategy. A...

September 5, 2023, 1:30 am

How much upside is left in zevra therapeutics (zvra)? wall street analysts think 248.51%

The consensus price target hints at a 248.5% upside potential for zevra Therapeutics (ZVRA). While empi...

September 4, 2023, 11:16 am

Acer (acer) to get acquired by zevra for $91m, stock up

Acer (ACER) surges as zevra Therapeutics offers to acquire it for approximately $91 million....

September 1, 2023, 9:02 am

Why is acer therapeutics (acer) stock up 85% today?

Acer Therapeutics (NASDAQ: ACER ) stock is taking off on Thursday after the pharmaceutical company announced an acquisition deal with ...

August 31, 2023, 8:49 am

zevra therapeutics appoints thomas anderson to board of directors and announces retirement of matthew r. plooster

CELEBRATION, Fla., Aug. 07, 2023 (GLOBE NEWSWIRE) — zevra Therapeutics (NasdaqGS: ZVRA) (“...

August 7, 2023, 8:45 pm

zevra therapeutics presents design of phase 2 clinical trial investigating kp1077 for the treatment of idiopathic hypersomnia (ih) at beyond sleepy 2023

zevra is a corporate sponsor of the Hypersomnia Foundation and Beyond Sleepy Conference CELEBRATION, Fl...

June 3, 2023, 11:30 am

zevra therapeutics (zvra) reports q1 loss, tops revenue estimates

zevra Therapeutics (ZVRA) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus ...

May 15, 2023, 6:59 pm

zevra therapeutics to report first quarter 2023 results on may 15, 2023

CELEBRATION, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (...

May 9, 2023, 7:30 am

zevra therapeutics, inc. (zvra) q4 2022 earnings call transcript

zevra Therapeutics, Inc. (NASDAQ:ZVRA ) Q4 2022 Earnings Conference Call March 7, 2023 8:30 AM ET Compa...

March 10, 2023, 3:24 pm

zevra therapeutics to present at 35th annual roth conference

CELEBRATION, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (“...

March 6, 2023, 7:30 am


Search within

Pages Search Results: